Properties (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:activities |
antagonist
|
| gptkbp:analyzes |
gptkb:Dr._John_Doe
|
| gptkbp:application |
research in neuroscience
|
| gptkbp:availability |
research use only
|
| gptkbp:campusFacilities |
gptkb:XYZ_University
|
| gptkbp:chemicalFormula |
NMR spectroscopy
reacts with nucleophiles thiazole derivatives stable under acidic conditions contains thiazole ring MSDS available C20H24N2O2S cell viability assay available_in_PubChem |
| gptkbp:clinicalTrials |
Phase 1
potential anti-cancer agent investigated for leukemia treatment |
| gptkbp:collaborations |
gptkb:ABC_Pharmaceuticals
with multiple institutions international research team |
| gptkbp:compatibleWith |
high potency
inhibits cell proliferation |
| gptkbp:composedOf |
solid-phase synthesis
via multi-step organic synthesis |
| gptkbp:dissolved |
soluble in DMSO
|
| gptkbp:environmentalImpact |
low toxicity
|
| gptkbp:formulation |
oral administration
|
| gptkbp:funding |
NIH grant
|
| https://www.w3.org/2000/01/rdf-schema#label |
MPD218
|
| gptkbp:impact |
nausea
|
| gptkbp:isATypeOf |
123456-78-9
|
| gptkbp:market |
not commercially available
|
| gptkbp:origin |
(2S)-2-amino-3-(4-(4-(dimethylamino)phenyl)-1,3-thiazol-2-yl)phenyl)propanoic acid
|
| gptkbp:patentAssignee |
gptkb:XYZ_University
|
| gptkbp:patentCitation |
US1234567B2
|
| gptkbp:patentStatus |
active
|
| gptkbp:publications |
Journal of Medicinal Chemistry
|
| gptkbp:regulatoryCompliance |
not approved for clinical use
|
| gptkbp:related_to |
MPD217
|
| gptkbp:releaseYear |
2010
|
| gptkbp:research_areas |
cancer therapy
|
| gptkbp:research_focus |
drug development
|
| gptkbp:researchAndDevelopment |
promising results
|
| gptkbp:safety_features |
extensively studied
|
| gptkbp:safetyFeatures |
handle with care
|
| gptkbp:storage |
room temperature, dry place
|
| gptkbp:targets |
human cells
kinase enzyme dopamine receptor |
| gptkbp:technique |
HPLC
|
| gptkbp:triggerType |
inhibits specific enzyme
|
| gptkbp:weight |
356.48 g/mol
|